Christopher T. Giordano
2022
In 2022, Christopher T. Giordano earned a total compensation of $667.3K as President and Chief Executive Officer at Tenax Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $144,750 |
---|---|
Option Awards | $104,296 |
Salary | $386,000 |
Other | $32,286 |
Total | $667,332 |
Giordano received $386K in salary, accounting for 58% of the total pay in 2022.
Giordano also received $144.8K in non-equity incentive plan, $104.3K in option awards and $32.3K in other compensation.
Rankings
In 2022, Christopher T. Giordano's compensation ranked 3,797th out of 5,538 executives tracked by ExecPay. In other words, Giordano earned more than 31.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,797 | 31st |
Manufacturing | 2,137 | 29th |
Chemicals And Allied Products | 1,025 | 24th |
Drugs | 960 | 23rd |
Pharmaceutical Preparations | 700 | 23rd |
Giordano's colleagues
We found two more compensation records of executives who worked with Christopher T. Giordano at Tenax Therapeutics in 2022.